Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics to Report Second Quarter 2021 Financial Results
July 22, 2021 16:30 ET | Travere Therapeutics, Inc.
SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter 2021 financial results on Thursday, July 29, 2021 after the close...
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
July 14, 2021 07:30 ET | Vera Therapeutics
SOUTH SAN FRANCISCO, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics Announces Presentation of Abstracts at ERA-EDTA Congress 2021
June 04, 2021 08:00 ET | Travere Therapeutics, Inc.
SAN DIEGO, June 04, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced presentations including nonclinical data examining the renal protective effects of sparsentan, a high...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics Completes Enrollment in Pivotal Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy
June 02, 2021 08:00 ET | Travere Therapeutics, Inc.
SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 PROTECT Study. The pivotal PROTECT Study is...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics to Present at Upcoming Investor Conferences
May 27, 2021 16:30 ET | Travere Therapeutics, Inc.
SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in...
Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics Reports First Quarter 2021 Financial Results
May 06, 2021 16:01 ET | Travere Therapeutics, Inc.
Pivotal PROTECT Study of sparsentan in IgA nephropathy nears completion of patient enrollment; topline proteinuria data expected 3Q21 Net product sales of $47.4 million for the first quarter of...
Cytta Name Logo.jpg
Cytta Premiers Exciting new Website and Scintillating Cytta Show Double Feature
April 07, 2021 08:00 ET | Cytta Corp.
Las Vegas , April 07, 2021 (GLOBE NEWSWIRE) -- --Cytta Corp (OTCPINK: CYCA) is pleased to announce the Company’s newly designed and updated website at https://cytta.com/ is up and running and...
Cytta Name Logo.jpg
Cytta’s IGAN System Helps First Responders Achieve Daily Record Setting Vaccination Totals
March 22, 2021 10:00 ET | Cytta Corp.
Las Vegas , March 22, 2021 (GLOBE NEWSWIRE) --  --Cytta Corp (OTCPINK: CYCA)To help deal with currently unprecedented Public Health crisis, Cytta provided our IGAN incident command technology to...
Cytta Name Logo.jpg
Texas Covid Vaccination Program Utilizing IGAN Screens on the YouTube Cytta Show
March 10, 2021 08:00 ET | Cytta Corp.
Las Vegas , March 10, 2021 (GLOBE NEWSWIRE) -- --Cytta Corp (OTCPINK: CYCA) We at Cytta are pleased and proud to be providing our IGAN incident command technology to assist in keeping Americans safe...
Cytta Name Logo.jpg
Initial Episode of the Cytta Show Screens on YouTube Today
March 03, 2021 08:00 ET | Cytta Corp.
Las Vegas , March 03, 2021 (GLOBE NEWSWIRE) --  --Cytta Corp (OTCPINK: CYCA) Cytta Corp. is pleased to announce that the inaugural version of the “Cytta Show” has now been posted on our YouTube...